Not applicableStudy completedNCT06192017What this trial is testingDevelopment of a Molecular Diagnostic Tool for Endometrial Cancer.Who this might be right forEndometrium Cancer MiMARK Diagnostics, S.L. 1,950
Testing effectiveness (Phase 2)Study completedNCT03345485What this trial is testingStudy of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.Who this might be right forSmall Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more Mundipharma Research Limited 71
Not applicableLooking for participantsNCT07544680What this trial is testingEndometrial Cancer Vaginal Fluid Specimen Collection StudyWho this might be right forAbnormal Uterine Bleeding (AUB)Endometrial CancerAtypical Endometrial Hyperplasia+2 more Exact Sciences Corporation 4,200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07605247What this trial is testingTirzepatide in the Treatment of Endometrial CancerWho this might be right forEndometrial Cancer Rutgers, The State University of New Jersey 30
Testing effectiveness (Phase 2)WithdrawnNCT05483023What this trial is testing18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone TherapyWho this might be right forComplex Atypical HyperplasiaEndometrial Cancer UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04474184What this trial is testingDevelopment of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death RatesWho this might be right forEndometrial Carcinoma Mayo Clinic 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07737795What this trial is testingEvaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial CancerWho this might be right forEndometrial Cancer University of Oklahoma 66
Testing effectiveness (Phase 2)Looking for participantsNCT07108270What this trial is testingDostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)Who this might be right forNeoplasms, Endometrial GlaxoSmithKline 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05611931What this trial is testingSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaWho this might be right forEndometrial Cancer Karyopharm Therapeutics Inc 257